Where I see patients (2)
My reviews
Selected research
-
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
Survival outcomes for lung neuroendocrine tumors in California differ by sociodemographic factors.
Endocrine-related cancer
-
Correction: Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report.
Cardio-oncology (London, England)
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 885-3882
4.9